摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

新庚酰氯 | 84788-19-2

中文名称
新庚酰氯
中文别名
——
英文名称
neoheptanoyl chloride
英文别名
4,4-dimethylpentanoyl chloride
新庚酰氯化学式
CAS
84788-19-2
化学式
C7H13ClO
mdl
——
分子量
148.633
InChiKey
JJWZQJJEKFKGNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    新庚酰氯 在 (2S)-N-methyl-1-phenylpropan-2-amine hydrate 、 sodium peroxide 、 正戊烷 作用下, 生成 bis-(4,4-dimethyl-valeryl)-peroxide
    参考文献:
    名称:
    Fieser et al., Journal of the American Chemical Society, 1948, vol. 70, p. 3177
    摘要:
    DOI:
  • 作为产物:
    描述:
    3,3-二甲基-1-丁酸吡啶氢氧化钾 、 lithium aluminium tetrahydride 、 氯化亚砜 作用下, 以 乙醚乙醇二甲基亚砜 为溶剂, 反应 24.0h, 生成 新庚酰氯
    参考文献:
    名称:
    Lee, Sueg-Geun, Journal of the Chemical Society. Perkin transactions II, 1993, # 7, p. 1361 - 1372
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides
    申请人:ELI LILLY AND COMPANY
    公开号:EP0825164A2
    公开(公告)日:1998-02-25
    This invention relates to a novel solution phase process for the preparation of amide, carbamate, and sulfonamide combinatorial libraries. These libraries have utility for drug discovery and are used to form wellplate components of novel assay kits.
    这项发明涉及一种用于制备酰胺、碳酸酯和磺酰胺组合库的新型溶液相过程。这些库在药物发现中具有实用价值,并用于形成新型检测套件的微孔板组件。
  • Meta-bis anilide derivatives and their utility as herbicides
    申请人:Stauffer Chemical Company
    公开号:US03937729A1
    公开(公告)日:1976-02-10
    Compounds corresponding to the formula: ##SPC1## In which R.sub.1 and R.sub.2 are, independently, hydrogen, alkyl, alkoxyalkyl, cycloalkyl, pinonyl, ethylcycloalkyl, lower alkenyl, halogenated lower alkyl, benzyl, ethylphenyl, 2,4-dichlorophenoxy-methylene, styryl, furyl, phenyl or substituted phenyl in which the substituents are nitro, halogen, methyl, or methoxy; R.sub.3 and R.sub.4 are, independently, hydrogen or lower alkyl; X and Y are independently oxygen or sulfur; and Z is halogen, nitro, amino, lower alkyl, lower alkoxy or trifluoromethyl and n is an integer having a value from 0 to 4. The above compounds are effective herbicides, particularly for the control of grasses and broadleaf plants with both pre-emergence and post-emergence activity. Representative compounds are: m-propionamidobutyranilide, m-bis-2,2-dimethylvaleranilide, m-isobutyramido trichloroacetanilide, m-isobutyramido-2-ethylbutyranilide, m-t-butylacetamidopropionanilide, and 3'-N-ethyl propionamido-propionalide. This application is a continuation of application Ser. No. 180,916, filed Sept. 15, 1971, which is a continuation of application Ser. No. 20,104, filed Mar. 16, 1970, which is a continuation-in-part of application Ser. No. 741,267, filed July 1, 1968, which is a continuation-in-part of application Ser. No. 659,865, filed Aug. 11, 1967, all now abandoned.
    符合公式:##SPC1## 的化合物,其中R1和R2分别独立地为氢、烷基、烷氧基烷基、环烷基、松香基、乙基环烷基、低级烯基、卤代低级烷基、苄基、乙基苯基、2,4-二氯苯氧基亚甲基、苯乙烯基、呋喃基、苯基或取代的苯基,其中取代基为硝基、卤素、甲基或甲氧基;R3和R4分别独立地为氢或低级烷基;X和Y分别独立地为氧或硫;Z为卤素、硝基、氨基、低级烷基、低级烷氧基或三氟甲基,n为0至4之间的整数。上述化合物是有效的除草剂,特别是用于控制具有苗前和苗后活性的禾本科植物和阔叶植物。代表性的化合物包括:m-丙酸酰胺丁酰替苯胺,m-双-2,2-二甲基戊替苯胺,m-异丁酰胺三氯乙酰替苯胺,m-异丁酰胺-2-乙基丁酰替苯胺,m-t-丁基乙酰胺丙酰替苯胺和3'-N-乙基丙酰胺丙酰替苯胺。此申请是1971年9月15日提交的申请Ser. No. 180,916的继续申请,该申请是1970年3月16日提交的申请Ser. No. 20,104的继续申请,该申请是1968年7月1日提交的申请Ser. No. 741,267的继续部分申请,该申请是1967年8月11日提交的申请Ser. No. 659,865的继续部分申请,所有这些申请现在都已放弃。
  • Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-c]quinolines
    作者:Hari Prasad Kokatla、Euna Yoo、Deepak B. Salunke、Diptesh Sil、Cameron F. Ng、Rajalakshmi Balakrishna、Subbalakshmi S. Malladi、Lauren M. Fox、Sunil A. David
    DOI:10.1039/c2ob26705e
    日期:——
    Toll-like receptor (TLR)-8 agonists typified by the 2-alkylthiazolo[4,5-c]quinolin-4-amine (CL075) chemotype are uniquely potent in activating adaptive immune responses by inducing robust production of T helper 1-polarizing cytokines, suggesting that TLR8-active compounds could be promising candidate vaccine adjuvants, especially for neonatal vaccines. Alkylthiazoloquinolines with methyl, ethyl, propyl and butyl groups at C2 displayed comparable TLR8-agonistic potencies; activity diminished precipitously in the C2-pentyl compound, and higher homologues were inactive. The C2-butyl compound was unique in possessing substantial TLR7-agonistic activity. Analogues with branched alkyl groups at C2 displayed poor tolerance of terminal steric bulk. Virtually all modifications at C8 led to abrogation of agonistic activity. Alkylation on the C4-amine was not tolerated, whereas N-acyl analogues with short acyl groups (other than acetyl) retained TLR8 agonistic activity, but were substantially less water-soluble. Immunization in rabbits with a model subunit antigen adjuvanted with the lead C2-butyl thiazoloquinoline showed enhancements of antigen-specific antibody titers.
    以2-烷基噻唑并[4,5-c]喹啉-4-胺(CL075)为化学类型的Toll样受体(TLR)-8激动剂,能独特地激活适应性免疫反应,通过诱导强大的T辅助1型细胞因子产生,表明TLR8激活化合物可能是有前景的候选疫苗佐剂,尤其是新生儿疫苗。在C2位带有甲基、乙基、丙基和丁基的烷基噻唑喹啉显示出相当的TLR8激动效力;C2戊基化合物的活性急剧下降,更高同系物则无活性。C2-丁基化合物独特地拥有显著的TLR7激动活性。在C2位带有支链烷基的类似物显示出对末端立体障碍的差耐受性。几乎所有在C8位的修饰都会导致激动活性的消除。C4-胺上的烷基化不被接受,而带有短酰基(除乙酰基外)的N-酰胺类似物保持了TLR8激动活性,但水溶性大大降低。用导联C2-丁基噻唑喹啉增强的模型亚单位抗原免疫兔子,显示出抗原特异性抗体滴度的增强。
  • Potassium Channel Modulators
    申请人:Xu Xiangdong
    公开号:US20120122888A1
    公开(公告)日:2012-05-17
    Disclosed herein are KCNQ potassium channels modulators of formula (I) wherein R 1 , R 2 , R 3 , R 4 , and R 5 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.
    本文披露了公式(I)中的KCNQ钾通道调节剂,其中R1、R2、R3、R4和R5如规范中所定义。还描述了包含这些化合物的组合物;以及使用这些化合物和组合物治疗疾病和疾病的方法。
  • Carboxyalkyl peptide derivatives
    申请人:G.D. Searle & Co.
    公开号:US04511504A1
    公开(公告)日:1985-04-16
    This invention encompasses novel carboxyalkyl peptide derivatives which are collagenase inhibitors.
    这项发明涵盖了新型的羧基烷基肽衍生物,它们是胶原酶抑制剂。
查看更多